365 related articles for article (PubMed ID: 18078350)
21. Surface structure of amyloid-beta fibrils contributes to cytotoxicity.
Yoshiike Y; Akagi T; Takashima A
Biochemistry; 2007 Aug; 46(34):9805-12. PubMed ID: 17676931
[TBL] [Abstract][Full Text] [Related]
22. Rapid assembly of amyloid-beta peptide at a liquid/liquid interface produces unstable beta-sheet fibers.
Nichols MR; Moss MA; Reed DK; Hoh JH; Rosenberry TL
Biochemistry; 2005 Jan; 44(1):165-73. PubMed ID: 15628857
[TBL] [Abstract][Full Text] [Related]
23. Molecular dynamics studies of hexamers of amyloid-beta peptide (16-35) and its mutants: influence of charge states on amyloid formation.
Han W; Wu YD
Proteins; 2007 Feb; 66(3):575-87. PubMed ID: 17115426
[TBL] [Abstract][Full Text] [Related]
24. Potential lead for an Alzheimer drug: a peptide that blocks intermolecular interaction and amyloid beta protein-induced cytotoxicity.
Kwak JW; Kim HK; Chae CB
J Med Chem; 2006 Aug; 49(16):4813-7. PubMed ID: 16884292
[TBL] [Abstract][Full Text] [Related]
25. Molecular modeling of two distinct triangular oligomers in amyloid beta-protein.
Zheng J; Yu X; Wang J; Yang JC; Wang Q
J Phys Chem B; 2010 Jan; 114(1):463-70. PubMed ID: 20014755
[TBL] [Abstract][Full Text] [Related]
26. Substitution of methionine 35 inhibits apoptotic effects of Abeta(31-35) and Abeta(25-35) fragments of amyloid-beta protein in PC12 cells.
Clementi ME; Misiti F
Med Sci Monit; 2005 Nov; 11(11):BR381-5. PubMed ID: 16258386
[TBL] [Abstract][Full Text] [Related]
27. Biophysical characterization of longer forms of amyloid beta peptides: possible contribution to flocculent plaque formation.
Lambermon MH; Rappaport RV; McLaurin J
J Neurochem; 2005 Dec; 95(6):1667-76. PubMed ID: 16300644
[TBL] [Abstract][Full Text] [Related]
28. Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta.
Wood SJ; Maleeff B; Hart T; Wetzel R
J Mol Biol; 1996 Mar; 256(5):870-7. PubMed ID: 8601838
[TBL] [Abstract][Full Text] [Related]
29. Probing the role of backbone hydrogen bonding in beta-amyloid fibrils with inhibitor peptides containing ester bonds at alternate positions.
Gordon DJ; Meredith SC
Biochemistry; 2003 Jan; 42(2):475-85. PubMed ID: 12525175
[TBL] [Abstract][Full Text] [Related]
30. Assessing the stability of Alzheimer's amyloid protofibrils using molecular dynamics.
Lemkul JA; Bevan DR
J Phys Chem B; 2010 Feb; 114(4):1652-60. PubMed ID: 20055378
[TBL] [Abstract][Full Text] [Related]
31. "Click peptides"--chemical biology-oriented synthesis of Alzheimer's disease-related amyloid beta peptide (abeta) analogues based on the "O-acyl isopeptide method".
Sohma Y; Kiso Y
Chembiochem; 2006 Oct; 7(10):1549-57. PubMed ID: 16915597
[TBL] [Abstract][Full Text] [Related]
32. Alzheimer beta-amyloid peptides: structures of amyloid fibrils and alternate aggregation products.
Gorman PM; Chakrabartty A
Biopolymers; 2001; 60(5):381-94. PubMed ID: 12115148
[TBL] [Abstract][Full Text] [Related]
33. Peptide inhibitors of beta-amyloid aggregation.
Doig AJ
Curr Opin Drug Discov Devel; 2007 Sep; 10(5):533-9. PubMed ID: 17786851
[TBL] [Abstract][Full Text] [Related]
34. Phage display affords peptides that modulate beta-amyloid aggregation.
Orner BP; Liu L; Murphy RM; Kiessling LL
J Am Chem Soc; 2006 Sep; 128(36):11882-9. PubMed ID: 16953628
[TBL] [Abstract][Full Text] [Related]
35. Hybrid peptides attenuate cytotoxicity of beta-amyloid by inhibiting its oligomerization: implication from solvent effects.
Sun X; Wu WH; Liu Q; Chen MS; Yu YP; Ma Y; Zhao YF; Li YM
Peptides; 2009 Jul; 30(7):1282-7. PubMed ID: 19397942
[TBL] [Abstract][Full Text] [Related]
36. Amyloid-beta aggregates formed at polar-nonpolar interfaces differ from amyloid-beta protofibrils produced in aqueous buffers.
Nichols MR; Moss MA; Reed DK; Hoh JH; Rosenberry TL
Microsc Res Tech; 2005 Jul; 67(3-4):164-74. PubMed ID: 16103999
[TBL] [Abstract][Full Text] [Related]
37. Poly-N-methylated amyloid beta-peptide (Abeta) C-terminal fragments reduce Abeta toxicity in vitro and in Drosophila melanogaster.
Pratim Bose P; Chatterjee U; Nerelius C; Govender T; Norström T; Gogoll A; Sandegren A; Göthelid E; Johansson J; Arvidsson PI
J Med Chem; 2009 Dec; 52(24):8002-9. PubMed ID: 19908889
[TBL] [Abstract][Full Text] [Related]
38. Hsp104 targets multiple intermediates on the amyloid pathway and suppresses the seeding capacity of Abeta fibrils and protofibrils.
Arimon M; Grimminger V; Sanz F; Lashuel HA
J Mol Biol; 2008 Dec; 384(5):1157-73. PubMed ID: 18851977
[TBL] [Abstract][Full Text] [Related]
39. Conformational dynamics of amyloid beta-protein assembly probed using intrinsic fluorescence.
Maji SK; Amsden JJ; Rothschild KJ; Condron MM; Teplow DB
Biochemistry; 2005 Oct; 44(40):13365-76. PubMed ID: 16201761
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of the formation of amyloid beta-protein fibrils using biocompatible nanogels as artificial chaperones.
Ikeda K; Okada T; Sawada S; Akiyoshi K; Matsuzaki K
FEBS Lett; 2006 Dec; 580(28-29):6587-95. PubMed ID: 17125770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
